Mode
Text Size
Log in / Sign up

U.S. report describes MIS-C inflammatory syndrome in children after COVID-19

Share
U.S. report describes MIS-C inflammatory syndrome in children after COVID-19
Photo by Dmytro Vynohradov / Unsplash

A health report from the United States describes cases of multisystem inflammatory syndrome in children (MIS-C) that have been observed following COVID-19 infection. MIS-C is a serious condition where different parts of the body, like the heart, lungs, or skin, can become inflamed. The report looked at children and adolescents in the U.S. who developed this syndrome.

The main finding is that MIS-C has been reported in children after they had COVID-19. The report does not provide specific numbers on how many children were affected or details about their symptoms. It also does not report on any specific safety concerns or side effects from treatments, as it is primarily a description of cases that occurred.

It is very important to understand that this is an observational report. This means health officials observed and reported these cases, but the report does not prove that COVID-19 causes MIS-C. It only shows that the two have been seen together. The report does not give information on how likely a child is to get MIS-C after COVID-19.

Readers should take from this that health authorities are monitoring a serious inflammatory condition in children that appears after COVID-19. This information helps doctors know what to look for. However, the report does not change what we know about the risks for most children, as it does not provide data on how common this syndrome is.

What this means for you:
A U.S. report describes MIS-C in children after COVID-19, but does not prove cause or show how common it is.
Share
More on COVID-19